from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1295/thrC

LFCtreatmentdescriptionclass of inhibitor

-2.590

Amikacinug/mL Amikacintranslation

-3.650

Cap5-10ug/mL Capreomycintranslation

-3.963

Rox10-50 ug/mL Roxithromycintranslation

-0.811

SM2-5 ug/mL Streptomycintranslation

-0.460

Tet5-10 ug/mL Tetracyclinetranslation

0.376

Rif0.2-5ug/mL Rifampicintranscription

-0.470

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.992

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.178

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.868

CPZ10-50 ug/mL Chlorpromazinerespiration

0.566

Clofazimine10-13 ug/mL Clofaziminerespiration

0.495

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.396

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.393

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.112

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.205

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.451

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.937

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.411

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.063

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.331

KCN5-20 ug/mL Potassium cyaniderespiration

0.612

NaN30.2-2 mM Sodium aziderespiration

0.081

Nigericin50 uM Nigericinrespiration

-0.649

TRC10-150 ug/mL Triclosanrespiration

-0.056

TRZ10-25 ug/mL Thioridazinerespiration

-0.401

Valinomycin0.5-10 uM Valinomycinrespiration

-0.580

ZnSO42 mM ZnSO4respiration

-0.057

menadione6-10 ug/mL Menadionerespiration

0.011

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.176

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.384

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.286

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.380

NRP_1Non-replicating persistence stage 1dosRassociated

0.533

Amp0.2mg/mL AmpicillincellWall

0.327

Cephalexin20-100 ug/mL CephalexincellWall

-0.017

Cerulenin0.32-5 ug/mL CerulenincellWall

0.481

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.460

EMB10-20 ug/mL EthambutolcellWall

0.322

Eta12-40 ug/mL EthionamidecellWall

0.578

INH0.2-0.4 ug/mL IsoniazidcellWall

0.463

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.805

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.416

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.353

BZA0.12 mg/mL BenzamidearomaticAmides

-0.127

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.008

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.148

H2O24 mM hydrogen peroxideDNAdamaging

-0.555

Levo10 ug/mL LevofloxacinDNAdamaging

0.210

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

3.209

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.593

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.188

UVUV-irradiationDNAdamaging

-0.063

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.068

Antimycin12.5-50 ug/mL Antimycin A?

-0.115

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.333

PA_110-50 ug/mL Antitubercular compound PA-1?

0.197

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.137

PA8240.2-2 ug/mL PA-824?

0.101

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.077

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.163

Verapamil50 uM Verapamil?

-0.039

mercaptoethanol2 mM 2-Mercaptoethanol?

0.079

methoxatin10-20 ug/mL Methoxatin?